| ProductNum | picture | CAS No. | Name and description | Formula | Quick order | 
|---|---|---|---|---|---|
| CL2880 | 
                         | 
                    94055-76-2 | 
                         Suplatast Tosylate (Synonyms: IPD-1151T; Suplatast Tosilate) 98+%  | 
                    C23H33NO7S2 | |
| HL1298 | 
                         | 
                    55290-63-6 | 
                         Atractylodin 98+%  | 
                    C13H10O | |
| CLA1350 | 
                         | 
                    1418205-77-2 | 
                         Bimekizumab 95+%  | 
                    — | |
| CLA1344 | 
                         | 
                    1357158-22-5 | 
                         Fletikumab (Anti-IL-20) 95+%  | 
                    — | |
| CLA1335 | 
                         | 
                    1350289-85-8 | 
                         Anti-Human IL-23 Monoclonal Antibody(Guselkumab) 95+%  | 
                    — | |
| CLA1317 | 
                         | 
                    1326244-10-3 | 
                         Tildrakizumab (Anti-IL-23a) 95+%  | 
                    — | |
| CLA1316 | 
                         | 
                    1190264-60-8 | 
                         Dupilumab (anti-IL-4Rα) 95+%  | 
                    — | |
| CLA1311 | 
                         | 
                    1331830-76-2 | 
                         Perakizumab (Anti-CTLA-8 / IL-17a) 95+%  | 
                    — | |
| CLA1298 | 
                         | 
                    1236278-28-6 | 
                         Clazakizumab (Anti-IL-6 / IFNb2) 95+%  | 
                    — | |
| CLA1288 | 
                         | 
                    1189541-98-7 | 
                         Sarilumab (anti-IL-6Rα) 95+%  | 
                    — | |
| CLA1285 | 
                         | 
                    1194585-53-9 | 
                         Sirukumab (Anti-IL-6 / IFNb2) 95+%  | 
                    — | |
| CLA1281 | 
                         | 
                    1143503-69-8 | 
                         Ixekizumab (Anti-CTLA-8 / IL-17a) 95+%  | 
                    — | |
| CLA1278 | 
                         | 
                    1174395-19-7 | 
                         Brodalumab (anti-IL17RA) 95+%  | 
                    — | |
| CLA1264 | 
                         | 
                    909875-08-7 | 
                         Enokizumab (Anti-IL-9) 95+%  | 
                    — | |
| CLA1257 | 
                         | 
                    1007223-17-7 | 
                         Olokizumab (Anti-IL-6 / IFNb2) 95+%  | 
                    — | |
| CLA1249 | 
                         | 
                    1044511-01-4 | 
                         Benralizumab (Anti-IL-5Ra/ CD125) 95+%  | 
                    — | |
| CLA1243 | 
                         | 
                    953400-68-5 | 
                         Lebrikizumab (Anti-IL-13) 95+%  | 
                    — | |
| CLA1242 | 
                         | 
                    1007106-86-6 | 
                         Fezakinumab (Anti-IL-22) 95+%  | 
                    — | |
| CLA1210 | 
                         | 
                    241473-69-8 | 
                         Reslizumab 95+%  | 
                    — | |
| CLA1205 | 
                         | 
                    468715-71-1 | 
                         Elsilimomab (Anti-IL-6 / IFNb2) 95+%  | 
                    — | |